Leidos Secures Prime Contract with ARPA-H to Propel Health Innovations

RESTON, Va. — Stepping into a pivotal role in healthcare advancement, Leidos LDOS, a prominent player in the Fortune 500® pantheon, has clinched a prime contract from the Advanced Research Projects Agency for Health (ARPA-H). Tasked with fostering groundbreaking health projects, this recently established federal agency chose Leidos as a key ally in pushing the boundaries of biomedical research.

Contract Details and Significance

The contract represents a sophisticated partnership model, utilizing a hybrid blend of firm fixed price and time and materials billing structures. This strategic engagement not only underscores the confidence ARPA-H has in Leidos's capabilities but also highlights the company's versatility in meeting complex project demands in the health sector.

Leidos at the Forefront of Innovation

Leidos, with roots extending back to the Science Applications International Corporation (SAIC), has evolved to be at the forefront of defense, aviation, information technology, and biomedical research. Leidos's current ventures, including its significant presence in the information technology domain through the acquisition of Lockheed Martin IS&GS, reflect its unwavering commitment to technological innovation and its comprehensive range of scientific, engineering, systems integration, and technical services.

With a rich history of executing complex initiatives and its powerhouse stature within the market, the company's latest contract with ARPA-H is expected to enhance Leidos's already substantial credentials and foster synergy across various sectors, thereby creating a ripple effect of innovation within public health research and development.

Leidos, Contract, ARPA-H